Éric Frisdal
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 11
- Cancer, Lipids, and Metabolism 8
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Surgery top 5%
- Cholesterol and Lipid Metabolism 11
- Lipoproteins and Cardiovascular Health 9
- Virology top 10%
-
- Drug Transport and Resistance Mechanisms 5
-
- Liver Disease Diagnosis and Treatment 5
-
- Pulmonary Hypertension Research and Treatments 5
Éric Frisdal
46 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 359
- Endocrinology, Diabetes and Metabolism 294
- Surgery 599
- Cardiology and Cardiovascular Medicine 297
- Virology 60
Countries citing papers authored by Éric Frisdal
This map shows the geographic impact of Éric Frisdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Frisdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Frisdal more than expected).
Fields of papers citing papers by Éric Frisdal
This network shows the impact of papers produced by Éric Frisdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Frisdal. The network helps show where Éric Frisdal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Éric Frisdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2021 | 2 | |
| 4 | 2018 | 54 | |
| 5 | 2014 | 7 | |
| 6 | 2013 | 45 | |
| 7 | 2012 | 32 | |
| 8 | 2011 | 91 | |
| 9 | 2005 | 47 | |
| 10 | 2005 | 119 | |
| 11 | 2002 | 22 | |
| 12 | 2001 | 33 | |
| 13 | 2001 | 76 | |
| 14 | 2001 | 84 | |
| 15 | 2000 | 19 | |
| 16 | 1998 | 11 | |
| 17 | 1997 | 148 | |
| 18 | 1992 | 36 | |
| 19 | 1990 | 20 | |
| 20 | 1990 | 33 |
About Éric Frisdal
Éric Frisdal is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Rheumatology, Surgery and Immunology, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (11 papers), Protease and Inhibitor Mechanisms (11 papers), Lipoproteins and Cardiovascular Health (9 papers), Cancer, Lipids, and Metabolism (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Drug Transport and Resistance Mechanisms (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). The work is most often cited by research in Cancer Research (359 citations), Endocrinology, Diabetes and Metabolism (294 citations), Surgery (599 citations), Cardiology and Cardiovascular Medicine (297 citations) and Virology (60 citations). Éric Frisdal has collaborated with scholars based in France, Australia and Lebanon. Frequent co-authors include Wilfried Le Goff, Maryse Guérin, Marie‐Pia d’Ortho, M. John Chapman, C. Lafuma, Serge Adnot, Saadia Eddahibi, Philippe Lesnik, A. Harf and Georgia Barlovatz‐Meimon. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, European Respiratory Journal, Atherosclerosis, International Journal of Molecular Sciences and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.